Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology

被引:79
作者
Luke, Barbara [1 ]
Gopal, Daksha [2 ]
Cabral, Howard [2 ]
Stern, Judy E. [3 ]
Diop, Hafsatou [4 ]
机构
[1] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, E Lansing, MI 48824 USA
[2] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[3] Dartmouth Hitchcock, Dept Obstet & Gynecol, Lebanon, NH USA
[4] Massachusetts Dept Publ Hlth, Boston, MA USA
关键词
adverse pregnancy outcomes; assisted reproductive technology; infertility; subfertility; IN-VITRO FERTILIZATION; POPULATION-BASED COHORT; TERM HEALTH OUTCOMES; BODY-MASS INDEX; PERINATAL OUTCOMES; ADVERSE PREGNANCY; SINGLETON PREGNANCIES; CHILDREN BORN; INFERTILITY TREATMENT; CARDIOVASCULAR RISK;
D O I
10.1016/j.ajog.2017.04.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Births to subfertile women, with and without infertility treatment, have been reported to have lower birthweights and shorter gestations, even when limited to singletons. It is unknown whether these decrements are due to parental characteristics or aspects of infertility treatment. OBJECTIVE: The objective of the study was to evaluate the effect of maternal fertility status on the risk of pregnancy, birth, and infant complications. STUDY DESIGN: All singleton live births of >= 22 weeks' gestation and >= 350 g birthweight to Massachusetts resident women in 2004-2010 were linked to hospital discharge and vital records. Women were categorized by their fertility status as in vitro fertilization, subfertile, or fertile. Women whose births linked to in vitro fertilization cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System were classified as in vitro fertilization. Women with indicators of subfertility but not treated with in vitro fertilization were classified as subfertile. Women without indicators of subfertility or in vitro fertilization treatment were classified as fertile. Risks of 15 adverse outcomes (gestational diabetes, pregnancy hypertension, antenatal bleeding, placental complications [placenta abruptio and placenta previa], prenatal hospitalizations, primary cesarean delivery, very low birthweight [< 1500 g], low birthweight [< 2500 g], small-for-gestation birthweight [z-score <= -1.28], large-for-gestation birthweight [z-score >= 1.28], very preterm [< 32 weeks], preterm [< 37 weeks], birth defects, neonatal death [0-27 days], and infant death [0-364 days of life]) were modeled by fertility status with the fertile group as reference and the subfertile group as reference, using multivariate log binomial regression and reported as adjusted risk ratios and 95% confidence intervals. RESULTS: The study population included 459,623 women (441,420 fertile, 8054 subfertile, and 10,149 in vitro fertilization). Women in the subfertile and in vitro fertilization groups were older than their fertile counterparts. Risks for 6 of 6 pregnancy outcomes and 6 of 9 infant outcomes were increased for the subfertile group, and 5 of 6 pregnancy outcomes and 7 of 9 infant outcomes were increased for the in vitro fertilization group. For 4 of the 6 pregnancy outcomes (uterine bleeding, placental complications, prenatal hospitalizations, and primary cesarean) and 2 of the infant outcomes (low birthweight and preterm) the risk was greater in the in vitro fertilization group, with nonoverlapping confidence intervals to the subfertile group, indicating a substantially higher risk among in vitro fertilizationetreated women. The highest risks for the in vitro fertilization women were uterine bleeding (adjusted risk ratio, 3.80; 95% confidence interval, 3.31-4.36) and placental complications (adjusted risk ratio, 2.81; 95% confidence interval, 2.57-3.08), and for in vitro fertilization infants, very preterm birth (adjusted risk ratio, 2.13; 95% confidence interval, 1.80-2.52), and very low birthweight (adjusted risk ratio, 2.15; 95% confidence interval, 1.80-2.56). With subfertile women as reference, risks for the in vitro fertilization group were significantly increased for uterine bleeding, placental complications, prenatal hospitalizations, primary cesarean delivery, low and very low birthweight, and preterm and very preterm birth. CONCLUSION: These analyses indicate that, compared with fertile women, subfertile and in vitro fertilizationetreated women tend to be older, have more preexisting chronic conditions, and are at higher risk for adverse pregnancy outcomes, particularly uterine bleeding and placental complications. The greater risk in in vitro fertilizationetreated women may reflect more severe infertility, more extensive underlying pathology, or other unfavorable factors not measured in this study.
引用
收藏
页码:327.e1 / 327.e14
页数:14
相关论文
共 111 条
  • [1] [Anonymous], 2014, 2012 assisted reproductive technology success rates: national summary and fertility clinic reports
  • [2] Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles
    Baker, Valerie L.
    Brown, Morton B.
    Luke, Barbara
    Smith, George W.
    Ireland, James J.
    [J]. FERTILITY AND STERILITY, 2015, 104 (05) : 1145 - +
  • [3] Association of number of retrieved oocytes with live birth rate and birth weight: an analysis of 231,815 cycles of in vitro fertilization
    Baker, Valerie L.
    Brown, Morton B.
    Luke, Barbara
    Conrad, Kirk P.
    [J]. FERTILITY AND STERILITY, 2015, 103 (04) : 931 - U101
  • [4] Severe Maternal Morbidity and the Use of Assisted Reproductive Technology in Massachusetts
    Belanoff, Candice
    Declercq, Eugene R.
    Diop, Hafsatou
    Gopal, Daksha
    Kotelchuck, Milton
    Luke, Barbara
    Thien Nguyen
    Stern, Judy E.
    [J]. OBSTETRICS AND GYNECOLOGY, 2016, 127 (03) : 527 - 534
  • [5] Folic Acid Supplementation for the Prevention of Neural Tube Defects US Preventive Services Task Force Recommendation Statement
    Bibbins-Domingo, Kirsten
    Grossman, David C.
    Curry, Susan J.
    Davidson, KarinaW.
    Epling, John W., Jr.
    Garcia, Francisco A. R.
    Kemper, Alex R.
    Krist, Alex H.
    Kurth, Ann E.
    Landefeld, C. Seth
    Mangione, Carol M.
    Phillips, William R.
    Phipps, Maureen G.
    Pignone, Michael P.
    Silverstein, Michael
    Tseng, Chien-Wen
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (02): : 183 - 189
  • [6] Perinatal outcomes of twin births conceived using assisted reproduction technology: a population-based study
    Boulet, Sheree L.
    Schieve, Laura A.
    Nannini, Angela
    Ferre, Cynthia
    Devine, Owen
    Cohen, Bruce
    Zhang, Zi
    Wright, Victoria
    Macaluso, Maurizio
    [J]. HUMAN REPRODUCTION, 2008, 23 (08) : 1941 - 1948
  • [7] Assisted Reproductive Technology and Birth Defects Among Liveborn Infants in Florida, Massachusetts, and Michigan, 2000-2010
    Boulet, Sheree L.
    Kirby, Russell S.
    Reefhuis, Jennita
    Zhang, Yujia
    Sunderam, Saswati
    Cohen, Bruce
    Bernson, Dana
    Copeland, Glenn
    Bailey, Marie A.
    Jamieson, Denise J.
    Kissin, Dmitry M.
    [J]. JAMA PEDIATRICS, 2016, 170 (06)
  • [8] The adverse effects of obesity on conception and implantation
    Brewer, Christopher J.
    Balen, Adam H.
    [J]. REPRODUCTION, 2010, 140 (03) : 347 - 364
  • [9] Variation in newborn size according to pregnancy weight change by trimester
    Brown, JE
    Murtaugh, MA
    Jacobs, DR
    Margellos, HC
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (01) : 205 - 209
  • [10] Preterm Delivery and Later Maternal Cardiovascular Disease Risk
    Catov, Janet M.
    Newman, Anne B.
    Roberts, James M.
    Kelsey, Sheryl F.
    Sutton-Tyrrell, Kim
    Harris, Tamara B.
    Colbert, Lisa
    Rubin, Susan M.
    Satterfield, Suzanne
    Ness, Roberta B.
    [J]. EPIDEMIOLOGY, 2007, 18 (06) : 733 - 739